The Desmond Tutu HIV Foundation (DTHF) in association with the Desmond Tutu HIV Centre (DTHC), an accredited research centre at the University of Cape Town’s (UCT) Institute of Infectious Disease and Molecular Medicine (IDM), has been working to accommodate and incorporate COVID-19 research and trials at its existing HIV and tuberculosis (TB) research sites.
Since its inception in 2004, the DTHF has established several clinical research sites in under-resourced communities in South Africa, while focusing on communities at high risk of contracting HIV and TB. Through community partnerships and efforts, the foundation also collaborates with those most at risk in order to find innovative solutions to prevent and treat HIV, TB and other related infections.
To date, the foundation has expanded its clinical trial capacity throughout the country – this process has allowed scientists to conduct large community-based trials in HIV and TB, which include trials in vaccine development, prevention and treatment.
In February 2019 the DTHC Masiphumelele research site launched a new Aerobiology TB Research Facility, which focuses on the study of the transmission of TB organisms with a view to finding ways to halt the spread of the disease.
“We are already adapting our sites to be COVID-19 safe.”
Professor Linda-Gail Bekker, the DTHF’s chief operating officer, said in a recent interview that in light of the current COVID-19 pandemic, adapting the sites to incorporate research related to COVID-19 was essential.
“We are already adapting our sites to be COVID-19 safe. By this I mean improving the infection control measures so that we can include COVID-19-related research there,” she said.
“The infrastructure exists, so we can do this efficiently and affordably.”
Pivoting to include COVID-19 research
The renewed focus on COVID-19 research doesn’t mean HIV and TB clinical trials have taken a back seat at testing sites. On the contrary, Bekker stressed, work is continuing in earnest.
“With this new research addition, we are still able to continue the HIV and TB work we have been doing. This is critical for the well-being of the country long term, while at the same time pivoting to include COVID-19 product research,” she said.
Bekker explained that research related to COVID-19 at DTHF sites will focus on developing vaccines, monoclonals (forming a clone derived from a single individual or cell), pre-exposure prophylaxis, and therapeutics.
Behind the scenes, she said, ensuring that testing sites are COVID-19 safe and ready, and adhering to the National Department of Health’s strict guidelines, has been a top priority.
But with new ventures come new challenges, she pointed out.
In this case, Bekker said, operations at testing sites came to a grinding halt when the COVID-19 pandemic hit the country. This as teams regrouped and tried to figure out the best way to move forward.
“We needed to restart our engines.”
To ensure sites were COVID-19 compliant, Bekker said spaces needed to be modified and extended accordingly, and in some cases, rebuilt.
“We are all moving forward. I think some [testing sites] are more ahead than others, but now we feel the urgency to get moving.”
Additions such as screens, outdoor tents, additional workspaces and more hand-washing stations were also made available.
“Emotionally, we also needed to get our heads right on how to do this, and if you like, to get back on the bike,” she said.
Progress has been swift, Bekker added.
“We are all moving forward. I think some [testing sites] are more ahead than others, but now we feel the urgency to get moving,” she said.
“[COVID-19] proposals and products are coming in and need to be tested. At the same time, all of our HIV and TB work needs to continue, urgently, or delays will damage those processes.”
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Please view the republishing articles page for more information.
COVID-19 is a global pandemic that caused President Cyril Ramaphosa to declare a national disaster in South Africa on 15 March and implement a national lockdown from 26 March.
UCT is taking the threat of infection in our university community extremely seriously, and this page will be updated regularly with the latest COVID-19 information.
Getting credible, evidence-based, accessible information and recommendations relating to COVID-19
The Department of Medicine at the University of Cape Town and Groote Schuur Hospital, are producing educational video material for use on digital platforms and in multiple languages. The information contained in these videos is authenticated and endorsed by the team of experts based in the Department of Medicine. Many of the recommendations are based on current best evidence and are aligned to provincial, national and international guidelines. For more information on UCT’s Department of Medicine, please visit the website.
To watch more videos like these, visit the Department of Medicine’s YouTube channel.
As the COVID-19 crisis drags on and evolves, civil society groups are responding to growing and diversifying needs – just when access to resources is becoming more insecure, writes UCT’s Prof Ralph Hamann.03 Jul 2020 - 6 min read Republished
The Covid-19 crisis has reinforced the global consequences of fragmented, inadequate and inequitable healthcare systems and the damage caused by hesitant and poorly communicated responses.24 Jun 2020 - >10 min read Opinion
Our scientists must not practise in isolation, but be encouraged to be creative and increase our knowledge of the needs of developing economies, write Professor Mamokgethi Phakeng, vice-chancellor of UCT, and Professor Thokozani Majozi from the University of the Witwatersrand.09 Jun 2020 - 6 min read Republished
South Africa has been recognised globally for its success in flattening the curve, which came as a result of President Ramaphosa responding quickly to the crisis, writes Prof Alan Hirsch.28 Apr 2020 - 6 min read Republished
In an email to the UCT community, Vice-Chancellor Professor Mamokgethi Phakeng said:
“COVID-19, caused by the virus SARS-CoV-2, is a rapidly changing epidemic. [...] Information [...] will be updated as and when new information becomes available.”
We are continuing to monitor the situation and we will be updating the UCT community regularly – as and when there are further updates. If you are concerned or need more information, students can contact the Student Wellness Service on 021 650 5620 or 021 650 1271 (after hours), while staff can contact 021 650 5685.